Amanta Healthcare Limited (NSE:AMANTA)
150.27
-6.87 (-4.37%)
At close: Jun 16, 2026
Amanta Healthcare Revenue
In the fiscal year ending March 31, 2026, Amanta Healthcare had annual revenue of 2.88B INR with 4.72% growth. Amanta Healthcare had revenue of 769.95M in the quarter ending March 31, 2026, with 6.84% growth.
Revenue
2.88B
Revenue Growth
+4.72%
P/S Ratio
1.79
Revenue / Employee
5.51M
Employees
522
Market Cap
5.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.88B | 129.69M | 4.72% |
| Mar 31, 2025 | 2.75B | -56.32M | -2.01% |
| Mar 31, 2024 | 2.80B | 212.11M | 8.19% |
| Mar 31, 2023 | 2.59B | 336.88M | 14.94% |
| Mar 31, 2022 | 2.25B | 541.47M | 31.61% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anuh Pharma | 7.72B |
| Sudarshan Pharma Industries | 7.03B |
| Kopran | 6.81B |
| Wanbury | 6.50B |
| ZIM Laboratories | 3.74B |
| Bharat Parenterals | 3.45B |
| Albert David | 3.34B |
| Hexagon Nutrition | 3.25B |